275 related articles for article (PubMed ID: 10370381)
21. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
22. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
[TBL] [Abstract][Full Text] [Related]
23. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
[TBL] [Abstract][Full Text] [Related]
24. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
Khayyamian S; Hutloff A; Büchner K; Gräfe M; Henn V; Kroczek RA; Mages HW
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6198-203. PubMed ID: 11983910
[TBL] [Abstract][Full Text] [Related]
25. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
26. CD 80(B7-1) expression on human tumor cell lines and its costimulatory signals for T cell proliferation and cytokine production.
Yan J; Ma B; Guo X; Sun Y; Zhang J; Zhang H
Chin Med J (Engl); 1998 Mar; 111(3):269-71. PubMed ID: 10374432
[TBL] [Abstract][Full Text] [Related]
27. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
[TBL] [Abstract][Full Text] [Related]
28. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
[TBL] [Abstract][Full Text] [Related]
29. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
30. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
31. The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication.
Barker E; Bossart KN; Fujimura SH; Levy JA
Cell Immunol; 1999 Sep; 196(2):95-103. PubMed ID: 10527561
[TBL] [Abstract][Full Text] [Related]
32. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
Delgado M; Reduta A; Sharma V; Ganea D
J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
[TBL] [Abstract][Full Text] [Related]
33. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line.
Park HY; Park JY; Kim JW; Lee MJ; Jang MJ; Lee SY; Baek DW; Park YM; Lee SW; Yoon S; Bae YS; Kwak JY
Int Immunopharmacol; 2004 Dec; 4(13):1587-601. PubMed ID: 15454112
[TBL] [Abstract][Full Text] [Related]
35. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells.
Lombardi G; Arnold K; Uren J; Marelli-Berg F; Hargreaves R; Imami N; Weetman A; Lechler R
Eur J Immunol; 1997 Jan; 27(1):62-71. PubMed ID: 9021999
[TBL] [Abstract][Full Text] [Related]
36. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
Jun HX; Jun CY; Yu ZX
Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
[TBL] [Abstract][Full Text] [Related]
37. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
[TBL] [Abstract][Full Text] [Related]
38. CD80 and CD86 expression on LPS-stimulated monocytes and the effect of CD80 and CD86 blockade on IL-4 and IFN-gamma production in nonatopic bronchial asthma.
Rutkowski R; Moniuszko T; Stasiak-Barmuta A; Kosztyła-Hojna B; Alifier M; Rutkowski K; Tatarczuk-Krawiel A
Arch Immunol Ther Exp (Warsz); 2003; 51(6):421-8. PubMed ID: 14692664
[TBL] [Abstract][Full Text] [Related]
39. Human B7-1 is more efficient than B7-2 in providing co-stimulation for alloantigen-specific T cells.
van Dijk AM; Otten HG; Vercauteren SM; Kessler FL; de Boer M; Verdonck LF; de Gast GC
Eur J Immunol; 1996 Sep; 26(9):2275-8. PubMed ID: 8814278
[TBL] [Abstract][Full Text] [Related]
40. Identification of a dynamic intracellular reservoir of CD86 protein in peripheral blood monocytes that is not associated with the Golgi complex.
Smyth C; Logan G; Weinberger RP; Rowe PB; Alexander IE; Smythe JA
J Immunol; 1998 Jun; 160(11):5390-6. PubMed ID: 9605139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
